NCT04682522View on ClinicalTrials.gov

Flagyl Microbiome in Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 21, 2021

Primary Completion Date

August 15, 2023

Study Completion Date

August 15, 2023

Conditions
Crohn Disease
Interventions
DRUG

Metronidazole Oral

250 mg Three times a day

Trial Locations (1)

40202

University Surgical Associates, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT04682522 - Flagyl Microbiome in Crohn's Disease | Biotech Hunter | Biotech Hunter